Skip to main content

. 1989 Jun 24;298(6689):1686–1687. doi: 10.1136/bmj.298.6689.1686

Tissue response of gastric mucosa after ingestion of fluoride.

C J Spak ¹, S Sjöstedt ¹, L Eleborg ¹, B Veress ¹, L Perbeck ¹, J Ekstrand ¹

PMCID: PMC1836770 PMID: 2503177

1686

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Lanza F. L. Endoscopic studies of gastric and duodenal injury after the use of ibuprofen, aspirin, and other nonsteroidal anti-inflammatory agents. Am J Med. 1984 Jul 13;77(1A):19–24. doi: 10.1016/s0002-9343(84)80014-5. [DOI] [PubMed] [Google Scholar]
Lecompte E. J. Clinical application of topical fluoride products--risks, benefits, and recommendations. J Dent Res. 1987 May;66(5):1066–1071. doi: 10.1177/00220345870660051701. [DOI] [PubMed] [Google Scholar]
Mamelle N., Meunier P. J., Dusan R., Guillaume M., Martin J. L., Gaucher A., Prost A., Zeigler G., Netter P. Risk-benefit ratio of sodium fluoride treatment in primary vertebral osteoporosis. Lancet. 1988 Aug 13;2(8607):361–365. doi: 10.1016/s0140-6736(88)92834-6. [DOI] [PubMed] [Google Scholar]
Pashley D. H., Allison N. B., Easmann R. P., McKinney R. V., Horner J. A., Whitford G. M. The effects of fluoride on the gastric mucosa of the rat. J Oral Pathol. 1984 Oct;13(5):535–545. doi: 10.1111/j.1600-0714.1984.tb01454.x. [DOI] [PubMed] [Google Scholar]
Riggs B. L., Hodgson S. F., Hoffman D. L., Kelly P. J., Johnson K. A., Taves D. Treatment of primary osteoporosis with fluoride and calcium. Clinical tolerance and fracture occurrence. JAMA. 1980 Feb 1;243(5):446–449. [PubMed] [Google Scholar]

ACTIONS

RESOURCES